FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:203 January 8, 2004 Number 2

PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Pfeffer, M. A.

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both . On page 1896, in Table 1, the entry "Left ventricular ejection fraction" should not have been followed by a footnote symbol (), as printed.

This article has been cited by other articles:

• Hennekens, C. H., Kowalczykowski, M., Hollar, D. (2006). Lack of Deleterious Interaction Between Angiotensin Receptor Blockers and {beta}-Blockers in the Treatment of Patients With Heart Failure. J CARDIOVASC PHARMACOL THER 11: 149-152 [Abstract]